Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trop-2 antigen is a multifunctional membrane protein central to oncogenic processes across many solid tumors due to its roles in cellular signaling related to growth/proliferation/invasion/survival. Its restricted expression pattern outside malignant contexts makes it an ideal candidate for targeted therapies currently revolutionizing outcomes for patients with advanced cancers expressing this marker.
Antibody-drug conjugate targeting Trop-2 delivers cytotoxic payload to cancer cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trophoblast Cell Surface Antigen 2 (Trop-2).